VRDN Viridian Therapeutics notches narrow Q4 2025 EPS beat but shares fall 358 percent on lukewarm investor sentiment AII Am Integrity Q4 2025 EPS beats estimates by 38 percent yet shares fall 227 percent in todays trading session MIRM Mirum Pharmaceuticals reports steep Q4 2025 EPS miss while shares post a small gain in todays trading Xcel Energy Inc XEL Q1 2026 Earnings Mixed TopLine Results InLine EPS Amid Sector Rotation Headwinds CWEN Clearway shares rise 568 percent despite reporting far wider Q4 2025 losses than analyst forecasts First Trust Natural Gas ETF FCG Positioned to Benefit from Structural European LNG Demand Amid Geopolitical Volatility Lam Research Corporation LRCX Named Top Semiconductor Capex Play By Jim Cramer Amid AIDriven Chip Supply Expansion Cycle Amazoncom Inc AMZN Emerges As Core Growth Channel Following Este Lauders Blowout Q3 Earnings Beat